IP Watchdog

JANUARY 8, 2024

The FCA claim was brought by patent attorney Zachary Silbersher against Valeant Pharmaceuticals, predecessor to Canadian drugmaker Bausch Health.

Pharmaceuticals 59

Pharmaceuticals Evidence Litigation 59

IP Watchdog

JUNE 21, 2022

Court of Appeals for the Federal Circuit issued a precedential decision in Novartis Pharmaceuticals Corp. Earlier today, the U.S. Accord Healthcare, Inc. granting a petition for rehearing from appellant HEC Pharm Co.,

Expert Testimony 59

Expert Testimony Pharmaceuticals Healthcare Evidence 59

IP Watchdog

AUGUST 26, 2021

The CAFC found that the jury’s verdict with respect to written description was not supported by substantial evidence. Court of Appeals for the Federal Circuit (CAFC) today reversed a jury verdict for Juno Therapeutics and Sloan Kettering Institute for Cancer Research (Juno), wiping out a $1.2 billion judgment for the entities.

Trial Brief 122

Trial Brief Evidence Technology Pharmaceuticals 122

IP Watchdog

JULY 13, 2023

On July 7, 2023, the district court invalidated the patent for lack of written description despite rejecting an enablement defense based upon the same evidence.

Technology 52

Technology Pharmaceuticals Construction Evidence 52

Evidence at Trial

NOVEMBER 10, 2021

The reality is that before a jury sees or hears any evidence, the judge first decides what the jury will see and hear. A preliminary fact is “a fact upon the existence or nonexistence of which depends the admissibility or inadmissibility of evidence.” ” Fed. ” Cal. Code § 400. See e.g. , Cal.

Burden Of Proof 52

Burden Of Proof Admissibility Evidence Witnesses 52

The Barrister

APRIL 1, 2025

Opponents of capital punishment argue that the system is deeply flawed, with risks of wrongful executions, racial and economic biases, and a lack of evidence supporting its claim as a powerful deterrent effect. Fatal Flaws: The Case Against the Death Penalty. 9 III.B.

Legal Precedent 40

Legal Precedent Evidence Pharmaceuticals Precedent 40

Evidence at Trial

NOVEMBER 27, 2021

Beyond knowing the mechanics of the rules of evidence, effective advocates use the rules as weapons of persuasion. Equally important is the ability to adjust to the constantly changing landscape of admitted and excluded evidence. If a key piece of evidence is excluded, pivoting to "Plan B" is essential. Last month's Strobel v.

Evidence 52

Evidence Witnesses Jury Instructions Objections 52

CaseFox

NOVEMBER 27, 2023

From the traditional focus on environmental and occupational hazards to the exploration of new frontiers in pharmaceuticals and consumer products. Cases related to pharmaceutical drugs, consumer products, and emerging contaminants in drinking water are gaining prominence.

Litigation 52

Litigation Pharmaceuticals Expert Testimony Evidence 52

Practice of Law

OCTOBER 15, 2024

All of these are major pharmaceutical companies with extensive histories and significant roles in the development, manufacturing, and distribution of medications – and one in particular: ranitidine. GSK still has not admitted wrongdoing, citing a lack of consistent evidence linking ranitidine to cancer. state courts.

Manufacturing 40

Manufacturing Pharmaceuticals Expert Testimony Evidence 40

Complex Discovery

NOVEMBER 3, 2024

As October 2024 concluded, it continues to be evident that the eDiscovery, cybersecurity, and information governance sectors are undergoing significant transformations. As AI becomes a critical tool in pharmaceutical innovation, it also presents challenges around data security, governance, and legal accountability. Read the update.

Government and Public Sector 69

Government and Public Sector Technology Cross-Examination Energy and Utilities 69

IP Watchdog

JANUARY 19, 2023

Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) today jointly held an all-day listening session featuring speakers from patient advocacy and industry groups, academia, and brand and generic pharmaceutical companies who weighed in on the relationship between patents and affordable access to medicines.

Evidence 128

Evidence Pharmaceuticals 128

Evidence at Trial

SEPTEMBER 9, 2021

What is inadmissible character evidence (Rule 404(a)) to one judge might be admissible "other acts" evidence (Rule 404(b)) to another. Merrell Dow Pharmaceuticals, Inc. They and their parents sued Merrell Dow Pharmaceuticals, Inc. And when it comes to expert opinion testimony, there can be even more uncertainty.

Evidence 52

Evidence Expert Testimony Admissibility Cross-Examination 52

IP Watchdog

MARCH 11, 2024

The proponents promoting this hot house theory have seen it denounced by those who created the Bayh-Dole Act as being unauthorized under their law and seen evidence they can’t refute that it would have little impact on drug prices but would devastate small business entrepreneurs in all fields of federally supported research and development.

Evidence 119

Evidence Pharmaceuticals 119

Forensic Psychologist

OCTOBER 25, 2015

Unlike many purported disorders that are promoted by researchers or the pharmaceutical industry, sex addiction is a bottoms-up movement, with people self-diagnosing themselves via self-help books or quick-and-dirty Internet surveys.

Objections 52

Objections Pharmaceuticals Construction Discovery 52